Welcome to Immortality Is Here

Welcome to the Longevity Knowledge Center — your trusted source for clear, science-based insights into the biology of aging and the strategies to overcome it.

This is not hype. This is your roadmap to surviving—and thriving—into the era of radical life extension.

Whether you’re longevity-curious, health-optimized, or building your own protocol, this section will help you go from overwhelmed… to enlightened.

Living Long Enough To Live Forever

Top

Greg Bailey

Immortality is Here / Greg Bailey
Listing Category
Short Description
Juvenescence co‑founder financing late‑stage longevity startups.
Description

Former biotech analyst Dr. Greg Bailey teamed with Jim Mellon to create Juvenescence, a holding company that has invested $300 million across cell therapy, senolytics, and AI‑generated small molecules. Juvenescence’s portfolio includes LyGenesis (organ regeneration via lymph‑node scaffolding) and AgeX Therapeutics. Bailey’s strategy mirrors ‘big pharma’ pipelines but focused exclusively on aging biology. He is a familiar face at JP Morgan Healthcare Week and writes op‑eds urging pension funds to allocate to gerotherapeutics.

Role Type
Investor / Entrepreneur
Focus Area
Longevity Investment, Organ Regeneration
Platform Reach
LinkedIn, Conferences, Financial Media
Affiliation
Juvenescence
Impact Level
$300 M deployed; 12 portfolio companies